169 related articles for article (PubMed ID: 29390996)
1. Realising the right to sexual and reproductive health: access to essential medicines for medical abortion as a core obligation.
Perehudoff K; Berro Pizzarossa L; Stekelenburg J
BMC Int Health Hum Rights; 2018 Feb; 18(1):8. PubMed ID: 29390996
[TBL] [Abstract][Full Text] [Related]
2. Strengthening regional commitment to ensuring access to medical abortion medicines in WHO's South-East Asia region: report of a participatory assessment and workshop.
Upadhyay MT; Fusire T; Loi UR; Sorhaindo A; Salahuddin M; Hossain MA; Tshomo T; Mulati E; Daisy L; Anggraweni DP; Gultom T; Indrawati F; Jenyfa M; Than MM; Bhattarai B; Moonasinghe L; Mathota C; Jitruknatee A; Cham C; Ganatra B; Raina N
Reprod Health; 2024 May; 20(Suppl 1):191. PubMed ID: 38760864
[TBL] [Abstract][Full Text] [Related]
3. Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators.
Perehudoff K
Glob Health Action; 2020 Dec; 13(1):1699342. PubMed ID: 33131456
[TBL] [Abstract][Full Text] [Related]
4. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
[TBL] [Abstract][Full Text] [Related]
5. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities.
Grossman A; Prata N; Williams N; Ganatra B; Lavelanet A; Läser L; Asmani C; Elamin H; Ouedraogo L; Rahman MM; Conneh-Duworko MJ; Tehoungue BZ; Chanza H; Phiri H; Bhattarai B; Dhakal NP; Ojo OA; Afolabi K; Kabuteni TJ; Hailu BG; Moses F; Dlamini-Nqeketo S; Zulu T; Rehnström Loi U
Reprod Health; 2023 Apr; 20(Suppl 1):58. PubMed ID: 37041543
[TBL] [Abstract][Full Text] [Related]
6. Applying human rights to improve access to reproductive health services.
Shaw D; Cook RJ
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S55-9. PubMed ID: 22883913
[TBL] [Abstract][Full Text] [Related]
7. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries.
Perehudoff SK; Alexandrov NV; Hogerzeil HV
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii48-iii57. PubMed ID: 31816073
[TBL] [Abstract][Full Text] [Related]
8. Reproductive health information and abortion services: standards developed by the European Court of Human Rights.
Westeson J
Int J Gynaecol Obstet; 2013 Aug; 122(2):173-6. PubMed ID: 23773435
[TBL] [Abstract][Full Text] [Related]
9. Landscape assessment of the availability of medical abortion medicines in India.
Karna P; Sharma KA; Grossman A; Gupta M; Chatterjee T; Williams N; Prata N; Sorhaindo A; Läser L; Rehnström Loi U; Ganatra B; Chaudhary P
Reprod Health; 2024 Jun; 20(Suppl 1):193. PubMed ID: 38840263
[TBL] [Abstract][Full Text] [Related]
10. Adolescent sexual and reproductive health and universal health coverage: a comparative policy and legal analysis of Ethiopia, Malawi and Zambia.
Kangaude G; Coast E; Fetters T
Sex Reprod Health Matters; 2020 Dec; 28(2):1832291. PubMed ID: 33121392
[TBL] [Abstract][Full Text] [Related]
11. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
Petitet PH; Ith L; Cockroft M; Delvaux T
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
[TBL] [Abstract][Full Text] [Related]
12. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of constitutional support to enhance access to essential medicines as a human right to health in the Eastern Mediterranean region.
Elsayed LM
East Mediterr Health J; 2012 Jan; 18(1):77-84. PubMed ID: 22360015
[TBL] [Abstract][Full Text] [Related]
14. Medical abortion for Australian women: it's time.
De Costa CM
Med J Aust; 2005 Oct; 183(7):378-80. PubMed ID: 16201958
[TBL] [Abstract][Full Text] [Related]
15. How the Uruguayan Judiciary Shapes Access to High-Priced Medicines: A Critique through the Right to Health Lens.
Pizzarossa LB; Perehudoff K; Forte JC
Health Hum Rights; 2018 Jun; 20(1):93-105. PubMed ID: 30008555
[TBL] [Abstract][Full Text] [Related]
16. Global Survey of National Constitutions: Mapping Constitutional Commitments to Sexual and Reproductive Health and Rights.
Pizzarossa LB; Perehudoff K
Health Hum Rights; 2017 Dec; 19(2):279-293. PubMed ID: 29302182
[TBL] [Abstract][Full Text] [Related]
17. How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries.
Briggs J; Embrey M; Maliqi B; Hedman L; Requejo J
BMC Health Serv Res; 2018 Dec; 18(1):952. PubMed ID: 30526593
[TBL] [Abstract][Full Text] [Related]
18. A human rights approach to the WHO Model List of Essential Medicines.
Seuba X
Bull World Health Organ; 2006 May; 84(5):405-7; discussion 408-11. PubMed ID: 16710552
[TBL] [Abstract][Full Text] [Related]
19. Access to essential medicines in 195 countries: A human rights approach to sustainable development.
Perehudoff SK; Alexandrov NV; Hogerzeil HV
Glob Public Health; 2019 Mar; 14(3):431-444. PubMed ID: 30187828
[TBL] [Abstract][Full Text] [Related]
20. The impact of criminalisation on abortion-related outcomes: a synthesis of legal and health evidence.
de Londras F; Cleeve A; Rodriguez MI; Farrell A; Furgalska M; Lavelanet A
BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36581332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
